+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Diseases Drugs Market Research Reports

Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • December 2022
  • 72 Pages
  • Global
From
Influenzavirus B Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Influenzavirus B Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • December 2022
  • 235 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022

  • Report
  • December 2022
  • 43 Pages
  • Global
From
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape - Product Thumbnail Image

Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape

  • Report
  • October 2022
  • 60 Pages
  • Global
From
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • September 2022
  • 76 Pages
  • Global
From
Fungal Infections Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Fungal Infections Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2022
  • 82 Pages
  • Global
From
Human Papillomavirus Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Human Papillomavirus Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • July 2022
  • 452 Pages
  • Global
From
Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research - Product Thumbnail Image

Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research

  • Report
  • May 2022
  • 59 Pages
  • Global
From
Pseudomonas aeruginosa Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Pseudomonas aeruginosa Infections Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 153 Pages
  • Global
From
Clostridioides difficile Infections (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Clostridioides difficile Infections (Clostridium difficile Associated Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 257 Pages
  • Global
From
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Global Drug Sales Forecast - Q4, 2021 - Product Thumbnail Image

Coronavirus Disease 2019 (COVID-19) Analyst Consensus Global Drug Sales Forecast - Q4, 2021

  • Report
  • December 2021
  • 38 Pages
  • Global
From
Sepsis - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Sepsis - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 177 Pages
  • Global
From
Epstein-Barr Virus (HHV-4) Infections - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Epstein-Barr Virus (HHV-4) Infections - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 136 Pages
  • Global
From
Severe Sepsis and Septic Shock - Epidemiology Forecast to 2030 - Product Thumbnail Image

Severe Sepsis and Septic Shock - Epidemiology Forecast to 2030

  • Report
  • August 2021
  • 52 Pages
  • Global
From
Hepatitis B Virus Infection - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Hepatitis B Virus Infection - Global Drug Forecast and Market Analysis to 2029

  • Report
  • March 2021
  • 132 Pages
  • Global
From
HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal - Product Thumbnail Image

HIV: First-in-Class Therapies Target Major Unmet Needs Including Drug Resistance and Latency Reversal

  • Report
  • December 2019
  • 63 Pages
  • Global
From
Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028

  • Report
  • November 2019
  • 153 Pages
  • Asia Pacific
From
Malaria: Opportunity Analysis and Forecasts to 2027 - Product Thumbnail Image

Malaria: Opportunity Analysis and Forecasts to 2027

  • Report
  • November 2018
  • 164 Pages
  • Global
From
Seasonal Influenza: Competitive Landscape to 2026 - Product Thumbnail Image

Seasonal Influenza: Competitive Landscape to 2026

  • Report
  • November 2018
  • 49 Pages
  • Global
From
US Methicillin Resistant Staphylococcus Aureus Infections Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Methicillin Resistant Staphylococcus Aureus Infections Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Loading Indicator

The Infectious Diseases Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from common colds to more serious conditions such as HIV/AIDS, malaria, and tuberculosis. The market is highly competitive, with many companies vying for a share of the market. Infectious Diseases Drugs are typically developed through a combination of research and development, clinical trials, and regulatory approval. Companies in the market must also ensure that their products are safe and effective for use in humans. Some of the major players in the Infectious Diseases Drugs market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Johnson & Johnson. These companies are involved in the development and production of a wide range of drugs used to treat infectious diseases. Show Less Read more